These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1023 related items for PubMed ID: 11585724

  • 21. Characterization of the VEGF binding site on the Flt-1 receptor.
    Herley MT, Yu Y, Whitney RG, Sato JD.
    Biochem Biophys Res Commun; 1999 Sep 07; 262(3):731-8. PubMed ID: 10471394
    [Abstract] [Full Text] [Related]

  • 22. Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma.
    Strizzi L, Catalano A, Vianale G, Orecchia S, Casalini A, Tassi G, Puntoni R, Mutti L, Procopio A.
    J Pathol; 2001 Apr 07; 193(4):468-75. PubMed ID: 11276005
    [Abstract] [Full Text] [Related]

  • 23. Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells.
    Takagi H, King GL, Ferrara N, Aiello LP.
    Invest Ophthalmol Vis Sci; 1996 Jun 07; 37(7):1311-21. PubMed ID: 8641834
    [Abstract] [Full Text] [Related]

  • 24. Immunohistochemical localization of vascular endothelial growth factor (VEGF) and its two specific receptors, Flt-1 and KDR, in the porcine placenta and non-pregnant uterus.
    Winther H, Ahmed A, Dantzer V.
    Placenta; 1999 Jan 07; 20(1):35-43. PubMed ID: 9950143
    [Abstract] [Full Text] [Related]

  • 25. Solution structure of a phage-derived peptide antagonist in complex with vascular endothelial growth factor.
    Pan B, Li B, Russell SJ, Tom JY, Cochran AG, Fairbrother WJ.
    J Mol Biol; 2002 Feb 22; 316(3):769-87. PubMed ID: 11866530
    [Abstract] [Full Text] [Related]

  • 26. Flk-1 as a target for tumor growth inhibition.
    Strawn LM, McMahon G, App H, Schreck R, Kuchler WR, Longhi MP, Hui TH, Tang C, Levitzki A, Gazit A, Chen I, Keri G, Orfi L, Risau W, Flamme I, Ullrich A, Hirth KP, Shawver LK.
    Cancer Res; 1996 Aug 01; 56(15):3540-5. PubMed ID: 8758924
    [Abstract] [Full Text] [Related]

  • 27. Differential expression of the two VEGF receptors flt and KDR in placenta and vascular endothelial cells.
    Barleon B, Hauser S, Schöllmann C, Weindel K, Marmé D, Yayon A, Weich HA.
    J Cell Biochem; 1994 Jan 01; 54(1):56-66. PubMed ID: 8126087
    [Abstract] [Full Text] [Related]

  • 28. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases.
    Meyer M, Clauss M, Lepple-Wienhues A, Waltenberger J, Augustin HG, Ziche M, Lanz C, Büttner M, Rziha HJ, Dehio C.
    EMBO J; 1999 Jan 15; 18(2):363-74. PubMed ID: 9889193
    [Abstract] [Full Text] [Related]

  • 29. Coordinate expression of vascular endothelial growth factor receptor-1 (flt-1) and its ligand suggests a paracrine regulation of murine vascular development.
    Breier G, Clauss M, Risau W.
    Dev Dyn; 1995 Nov 15; 204(3):228-39. PubMed ID: 8573716
    [Abstract] [Full Text] [Related]

  • 30. Heterogeneous vascular endothelial growth factor (VEGF) isoform mRNA and receptor mRNA expression in human glomeruli, and the identification of VEGF148 mRNA, a novel truncated splice variant.
    Whittle C, Gillespie K, Harrison R, Mathieson PW, Harper SJ.
    Clin Sci (Lond); 1999 Sep 15; 97(3):303-12. PubMed ID: 10464055
    [Abstract] [Full Text] [Related]

  • 31. Eicosapentaenoic acid attenuates vascular endothelial growth factor-induced proliferation via inhibiting Flk-1 receptor expression in bovine carotid artery endothelial cells.
    Yang SP, Morita I, Murota SI.
    J Cell Physiol; 1998 Aug 15; 176(2):342-9. PubMed ID: 9648921
    [Abstract] [Full Text] [Related]

  • 32. VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism.
    Gerber HP, Malik AK, Solar GP, Sherman D, Liang XH, Meng G, Hong K, Marsters JC, Ferrara N.
    Nature; 2002 Jun 27; 417(6892):954-8. PubMed ID: 12087404
    [Abstract] [Full Text] [Related]

  • 33. Co-localization of vascular endothelial growth factor and its two receptors flt-1 and kdr in the mink placenta.
    Winther H, Dantzer V.
    Placenta; 2001 May 27; 22(5):457-65. PubMed ID: 11373156
    [Abstract] [Full Text] [Related]

  • 34. VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours.
    Ohta Y, Shridhar V, Bright RK, Kalemkerian GP, Du W, Carbone M, Watanabe Y, Pass HI.
    Br J Cancer; 1999 Sep 27; 81(1):54-61. PubMed ID: 10487612
    [Abstract] [Full Text] [Related]

  • 35. Uterine smooth muscle cells express functional receptors (flt-1 and KDR) for vascular permeability factor/vascular endothelial growth factor.
    Brown LF, Detmar M, Tognazzi K, Abu-Jawdeh G, Iruela-Arispe ML.
    Lab Invest; 1997 Feb 27; 76(2):245-55. PubMed ID: 9042161
    [Abstract] [Full Text] [Related]

  • 36. The vascular endothelial growth factor receptor KDR/Flk-1 is a major regulator of malignant ascites formation in the mouse hepatocellular carcinoma model.
    Yoshiji H, Kuriyama S, Hicklin DJ, Huber J, Yoshii J, Ikenaka Y, Noguchi R, Nakatani T, Tsujinoue H, Fukui H.
    Hepatology; 2001 Apr 27; 33(4):841-7. PubMed ID: 11283848
    [Abstract] [Full Text] [Related]

  • 37. Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells.
    Kanno S, Oda N, Abe M, Terai Y, Ito M, Shitara K, Tabayashi K, Shibuya M, Sato Y.
    Oncogene; 2000 Apr 20; 19(17):2138-46. PubMed ID: 10815805
    [Abstract] [Full Text] [Related]

  • 38. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.
    Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N, Alitalo K.
    EMBO J; 1996 Jan 15; 15(2):290-98. PubMed ID: 8617204
    [Abstract] [Full Text] [Related]

  • 39. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model.
    Nakabayashi M, Morishita R, Nakagami H, Kuba K, Matsumoto K, Nakamura T, Tano Y, Kaneda Y.
    Diabetologia; 2003 Jan 15; 46(1):115-23. PubMed ID: 12637990
    [Abstract] [Full Text] [Related]

  • 40. The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects.
    Béliveau R, Gingras D, Kruger EA, Lamy S, Sirois P, Simard B, Sirois MG, Tranqui L, Baffert F, Beaulieu E, Dimitriadou V, Pépin MC, Courjal F, Ricard I, Poyet P, Falardeau P, Figg WD, Dupont E.
    Clin Cancer Res; 2002 Apr 15; 8(4):1242-50. PubMed ID: 11948139
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 52.